SLNO - SOLENO THERAPEUTICS INC

52.75
0.060   0.114%

Share volume: 1,611,599
Last Updated: 04-22-2026
Medical Equipment/Surgical, Medical, And Dental Instruments And Supplies: -0.02%

PREVIOUS CLOSE
CHG
CHG%
$52.69
0.06
0.00%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Overview Charts Financials Fundamental analysis Historical prices Events Documents Notes Dividends
Fundamental analysis
19%
Profitability 0%
Dept financing 19%
Liquidity 56%
Performance 30%
Company vs Stock growth
vs
+ Add row to compare
Performance
5 Days
0.15%
1 Month
66.30%
3 Months
24.53%
6 Months
-17.14%
1 Year
-27.01%
2 Year
31.42%
Key data
Stock price
$52.75
P/E Ratio 
121.45
DAY RANGE
$52.70 - $52.80
EPS 
$0.40
52 WEEK RANGE
$29.43 - $90.32
52 WEEK CHANGE
-$28.94
MARKET CAP 
2.487 B
YIELD 
N/A
SHARES OUTSTANDING 
51.624 M
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
08-06-2025
BETA 
1.11
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$3,405,216
AVERAGE 30 VOLUME 
$6,898,679
Company detail
CEO: Anish Bhatnagar
Region: US
Website: soleno.life
Employees: 30
IPO year: 2017
Issue type: Common Stock
Market: XNAS
Industry: Medical Equipment/Surgical, Medical, And Dental Instruments And Supplies
Sector: Manufacturing

Soleno Therapeutics is a clinical-stage biopharmaceutical company. Its lead candidate is Diazoxide Choline Controlled-Release, a once-daily oral tablet for the treatment of Prader-Willi Syndrome. The company was formerly known as Capnia, Inc. and changed its name in May 2017.

Recent news